Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Quinidine sulphate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 375Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    USV Launches Quinidine Sulphate Tablets For heart arrhythmia
    USV Launches Quinidine Sulphate Tablets For heart arrhythmia

    26 Sep 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/usv-launches-quinidine-sulphate-tablets-to-address-rare-heart-arrhythmia/

    EXPRESSPHARMA
    26 Sep 2024
    Share Share
    Hetero`s Generics Dextromethorphan HBr, Quinidine Sulfate Receive Approval in US
    Hetero`s Generics Dextromethorphan HBr, Quinidine Sulfate Receive Approval in US

    28 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218426

    FDA
    28 Aug 2024
    Share Share
    Avanir Pharma to Continue Clinical Development of Investigational AVP-786
    Avanir Pharma to Continue Clinical Development of Investigational AVP-786

    12 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/avanir-pharmaceuticals-inc-to-continue-clinical-development-of-investigational-avp-786-for-the-treatment-of-agitation-in-patients-with-alzheimers-dementia-300956033.html

    PR NEWSWIRE
    12 Nov 2019
    Share Share
    Avanir’s week goes from bad to worse with Alzheimer’s stumble
    Avanir’s week goes from bad to worse with Alzheimer’s stumble

    02 Oct 2019

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/avanirs_week_goes_from_bad_to_worse_with_alzheimers_stumble_1311531

    Phil Taylor PMLIVE
    02 Oct 2019
    Share Share